Ahold Delhaize Settles Fraud Claims for $503,460

North Carolina will receive its share of a $40 million multistate settlement over alleged overcharges of federal health care programs for prescription drugs.

Updated on Nov. 2, 2026 in Financial Crime

Ahold Delhaize Settles Fraud Claims for $503,460

Live Poll

Do you trust large grocery chains to charge government health programs fairly?

North Carolina's Attorney General announced a $503,460 settlement with Ahold Delhaize, owner of Food Lion, over fraud allegations. The payment is part of a $40 million multistate agreement resolving claims that the company overcharged federal health care programs for prescription drugs.

Why it matters

The allegations center on supermarket discount programs that were reported to federal programs at higher prices, causing those programs to overpay for drugs. The settlement returns money to the state and signals enforcement against pricing practices affecting Medicare Part D, Medicaid, and TRICARE.

The $40 million multistate settlement resolves the whistleblower lawsuit originally filed in Pennsylvania, with state justice officials, other states, and federal authorities having participated in the investigation. North Carolina's $503,460 share is the state-level portion of that resolution.

The players

Ahold Delhaize

A multinational grocery retail holding company that owns Food Lion and other supermarket chains across North America and Europe.

Food Lion

A regional supermarket chain based in North Carolina and owned by Ahold Delhaize.

The details

Supermarkets discounted prescription drugs through savings programs while reporting higher prices to Medicare Part D, Medicaid, and TRICARE, causing federal programs to pay more than they should have. The case began as a whistleblower lawsuit filed in Pennsylvania before the multistate resolution.

November 2, 2026: North Carolina Attorney General announced the settlement with Ahold Delhaize.

Legal Context

Federal health care programs including Medicare Part D rely on pharmacy and retailer price reporting to set reimbursement amounts. This settlement shows states and federal authorities pursuing False Claims Act-style cases when reported prices diverge from what programs actually pay.

Residents of North Carolina who rely on Medicare Part D, Medicaid, or TRICARE for prescriptions are affected by the pricing practices at issue. The settlement funds return to the state, though the extraction does not state how they will be allocated.

The takeaway

Prescription drug prices reported to federal programs must match what pharmacies actually charge, and enforcement actions like this one hold retailers accountable when discount programs obscure true costs. Patients and taxpayers benefit when reporting is accurate.